Next Article in Journal
Organocatalyzed Asymmetric α-Oxidation, α-Aminoxylation and α-Amination of Carbonyl Compounds
Next Article in Special Issue
Control of Intracellular Calcium Signaling as a Neuroprotective Strategy
Previous Article in Journal
A New 1,4-Diazepine from South China Sea Marine Sponge Callyspongia Species
Previous Article in Special Issue
JNK Contributes to Hif-1α Regulation in Hypoxic Neurons
 
 
Review

3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future

1
Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Maimónides de Investigaciones Biomédicas de Córdoba (IMIBIC), Universidad de Córdoba, Av. Menéndez Pidal s/n, 14004 Córdoba, Spain
2
Laboratorio de Aminoácidos Excitadores, Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”, México D.F., Mexico
*
Author to whom correspondence should be addressed.
Molecules 2010, 15(2), 878-916; https://doi.org/10.3390/molecules15020878
Received: 9 December 2009 / Revised: 12 January 2010 / Accepted: 1 February 2010 / Published: 10 February 2010
(This article belongs to the Special Issue Neuroprotective Strategies)
Huntington’s disease (HD) is an inheritable autosomal-dominant disorder whose causal mechanisms remain unknown. Experimental models have begun to uncover these pathways, thus helping to understand the mechanisms implicated and allowing for the characterization of potential targets for new therapeutic strategies. 3-Nitropropionic acid is known to produce in animals behavioural, biochemical and morphologic changes similar to those occurring in HD. For this reason, this phenotypic model is gaining attention as a valuable tool to mimick this disorder and further developing new therapies. In this review, we will focus on the past and present research of this molecule, to finally bring a perspective on what will be next in this promising field of study. View Full-Text
Keywords: 3-nitropropionic acid; Huntington’s disease; quinolinic acid; succinate dehydrogenase; transgenic mice models 3-nitropropionic acid; Huntington’s disease; quinolinic acid; succinate dehydrogenase; transgenic mice models
Show Figures

Figure 1

MDPI and ACS Style

Túnez, I.; Tasset, I.; Pérez-De La Cruz, V.; Santamaría, A. 3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future. Molecules 2010, 15, 878-916. https://doi.org/10.3390/molecules15020878

AMA Style

Túnez I, Tasset I, Pérez-De La Cruz V, Santamaría A. 3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future. Molecules. 2010; 15(2):878-916. https://doi.org/10.3390/molecules15020878

Chicago/Turabian Style

Túnez, Isaac, Inmaculada Tasset, Verónica Pérez-De La Cruz, and Abel Santamaría. 2010. "3-Nitropropionic Acid as a Tool to Study the Mechanisms Involved in Huntington’s Disease: Past, Present and Future" Molecules 15, no. 2: 878-916. https://doi.org/10.3390/molecules15020878

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop